TAG / UN OFFICE ON DRUGS AND CRIME
RESULTS
MENTAL HEALTH
FDA Rejects Ecstasy for Psychiatric Use, Prompting Drugmaker to Lay Off 75% of Staff
Almost 100 percent of trial participants reported adverse events using this dangerous hallucinogen.
